J
Jennie R. Lill
Researcher at Genentech
Publications - 91
Citations - 9623
Jennie R. Lill is an academic researcher from Genentech. The author has contributed to research in topics: Ubiquitin ligase & Ubiquitin-conjugating enzyme. The author has an hindex of 31, co-authored 88 publications receiving 7675 citations. Previous affiliations of Jennie R. Lill include Torrey Pines Institute for Molecular Studies.
Papers
More filters
Journal ArticleDOI
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Nobuhiko Kayagaki,Irma B. Stowe,Bettina L. Lee,Karen O'Rourke,Keith R. Anderson,Søren Warming,Trinna L. Cuellar,Benjamin Haley,Merone Roose-Girma,Qui T. Phung,Peter Liu,Jennie R. Lill,Hong Li,Jiansheng Wu,Sarah K. Kummerfeld,Juan Zhang,Wyne P. Lee,Scott J. Snipas,Guy S. Salvesen,Lucy X. Morris,Linda Fitzgerald,Yafei Zhang,Edward M. Bertram,Christopher C. Goodnow,Christopher C. Goodnow,Christopher C. Goodnow,Vishva M. Dixit +26 more
TL;DR: It is shown that gasdermin D is essential for caspase-11-dependent pyroptosis and interleukin-1β maturation and a key mediator of the host response against Gram-negative bacteria.
Journal ArticleDOI
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav,Suchit Jhunjhunwala,Qui T. Phung,Patrick J. Lupardus,Joshua Tanguay,Stephanie M. Bumbaca,Christian Franci,Tommy K. Cheung,Jens Fritsche,Toni Weinschenk,Zora Modrusan,Ira Mellman,Jennie R. Lill,Lélia Delamarre +13 more
TL;DR: An approach that combines whole-exome and transcriptome sequencing analysis with mass spectrometry to identify neo-epitopes in two widely used murine tumour models indicates that a suitable prediction algorithm may provide an approach for the pharmacodynamic monitoring of T-cell responses as well as for the development of personalized vaccines in cancer patients.
Journal ArticleDOI
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Ingrid E. Wertz,Saritha Kusam,Cynthia Lam,Toru Okamoto,Wendy Sandoval,Daniel Anderson,Elizabeth Helgason,James A. Ernst,Mike Eby,Jinfeng Liu,Lisa D. Belmont,Joshua S. Kaminker,Karen O'Rourke,Kanan Pujara,Pawan Bir Kohli,Adam R. Johnson,Mark L. Chiu,Jennie R. Lill,Peter K. Jackson,Wayne J. Fairbrother,Somasekar Seshagiri,Mary J. C. Ludlam,Kevin G. Leong,Erin C. Dueber,Heather Maecker,David C.S. Huang,David C.S. Huang,Vishva M. Dixit +27 more
TL;DR: Highlights suggest that profiling the FBW7 and MCL1 status of tumours, in terms of protein levels, messenger RNA levels and genetic status, could be useful to predict the response of patients to antitubulin chemotherapeutics.
Journal ArticleDOI
Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling
Zhaoyu Jin,Yun Li,Robert M. Pitti,David A. Lawrence,Victoria Pham,Jennie R. Lill,Avi Ashkenazi +6 more
TL;DR: This work identifies a mechanism that positively controls apoptosis signaling by polyubiquitination and aggregation of a key initiator caspase through a previously unknown interaction of the DISC with a cullin3 (CUL3)-based E3 ligase.
Journal ArticleDOI
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
Martin Schwickart,XiaoDong Huang,Jennie R. Lill,Jinfeng Liu,Ronald E. Ferrando,Dorothy French,Heather Maecker,Karen O'Rourke,Fernando Bazan,Jeffrey Eastham-Anderson,Peng Yue,David Dornan,David C.S. Huang,Vishva M. Dixit +13 more
TL;DR: The results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.